Our services are centred around intellectual property that can be registered. We protect innovation, design, and branding across all sectors of industry, and at all stages in the supply chain.

For each IP right we offer services covering strategic advice, pre-registration searches, registrations and renewals, oppositions and dispute resolution. We handle work throughout the world, working with local colleagues in over 100 countries.


Our attorneys specialise in one or more sectors of industry, which enables them to provide quality advice with a commercial focus.

Our patent specialists have detailed understanding of the background technology, which ensures that your patent applications are prepared with the correct scope, reducing the likelihood of challenges from third parties and objections from the patent office.

They also advise whether other forms of protection would be more appropriate. Our brand specialists work with brand managers for leading brands and their advice is commercially focussed making sure that you get the best value from your budget.

30th Nov 2015

New FRAND developments in the UK high court

There are currently two cases before the UK High Court concerning standard-essential patents (SEPs) and FRAND1 licences. Although these cases do not directly follow from the Court of Justice of the European Union Decision in Huawei Technologies v ZTE2 in July 2015, they raise some interesting points with regard to FRAND defences and royalty rates […]

30th Nov 2015

As the PCT Direct service expands, is it time you went direct?

On 1 November 2014, the European Patent Office (EPO) introduced the PCT Direct service. Under the service, a Patent Cooperation Treaty (PCT) application using the EPO as the international searching authority, and claiming priority from an earlier application that has been searched by the EPO, can be filed along with comments responding to any objections […]

27th Nov 2015

Scanning for mistakes at the EPO

It is often said that prevention is better than cure, and this is certainly the case when it comes to correcting mistakes that make it into a granted patent specification. When the European Patent Office (EPO) intends to grant a European patent, they issue a Rule 71(3) communication which includes a copy of the text […]

20th Nov 2015

Poisonous priority – closer to an answer

Earlier in the year, we reported a referral to the Enlarged Board of Appeal from the Technical Board of Appeal (T 557/13) on the issue of poisonous priority. The questions to the Enlarged Board have now been finalised, and are as follows: Where a claim of a European patent application or patent encompasses alternative subject-matters […]

12th Nov 2015

Patent Box: what are the proposed changes?

The current UK Patent Box will close its lid to new entries at of the end of June 2016. On 22 October 2015, the UK Government published a consultation document proposing changes to the design of the Patent Box. The proposed changes are to ensure that it complies with the new international framework for preferential tax […]

9th Nov 2015

Off-patent drugs bill filibustered

The Off-patent Drugs Bill was effectively blocked on 6 November 2015, when a Conservative health minister spoke for twenty-seven minutes to “filibuster” the Bill, so it ran out of time. The Bill was designed to make potentially significant new treatments more available to patients, and improve efficiency within the NHS. An existing drug may be […]

6th Nov 2015

Off-patent drugs bill second reading

The Off-patent Drugs Bill is set to have its second reading debate on 6 November 2015. The Bill is discussed in a previous post and has now been published together with the explanatory notes and a briefing paper. Section 3 of the Bill provides for regulations which may specify “further requirements” that would need to be […]

Saved Staff
Staff member

Remove all

Saved profiles
Call +44 (0)20 7242 0901
Call +44 (0)1223 360 350
Call +49 (0) 89 206054 267
Call +(00) 31 70 800 2162


    Register for notifications
    Enter your email address here to receive our monthly bulletin of IP news and developments.

    "*" indicates required fields

    I confirm that I have read Reddie & Grose's privacy notice and consent to my personal information being collected*
    Please read our privacy notice.